Literature DB >> 8335021

Myoadenylate deaminase deficiency with severe rhabdomyolysis.

F A Baumeister1, M Gross, D R Wagner, D Pongratz, R Eife.   

Abstract

A 13-year-old Turkish girl was admitted because of recurrent episodes of muscle pain and weakness since the age of 5 years. As an outpatient she developed severe acute rhabdomyolysis (myoglobinuria and increased serum creatine kinase level of 19,000 units/l). The acute rhabdomyolysis and the preceding episodes of muscle pain and weakness had been induced by exercise. There was no increase in plasma ammonia level during ischaemic forearm exercise test and bicycle ergometry. Myoadenylate deaminase deficiency was proven both histochemically and biochemically. The girl was found to be homozygous for the C 34-T mutation of the AMPD1 gene causing primary myoadenylate deaminase deficiency in skeletal muscle. Both parents and her brother were heterozygous for that mutation. Myoadenylate deaminase deficiency has to be considered as a cause of severe rhabdomyolysis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8335021     DOI: 10.1007/bf01955062

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  12 in total

1.  Muscle metabolism and red cell ATP/ADP concentration during bicycle ergometer in patients with AMPD-deficiency.

Authors:  D R Wagner; J Felbel; U Gresser; N Zöllner
Journal:  Klin Wochenschr       Date:  1991-04-04

2.  Type 2a fibre rhabdomyolysis in myoadenylate deaminase deficiency.

Authors:  C Zimmer; H Altenkirch; S Dorfmüller-Küchlin; D Pongratz; I Paetzke; G Gosztonyi
Journal:  J Neurol       Date:  1991-02       Impact factor: 4.849

3.  Mutant carnitine palmitoyltransferase associated with myoadenylate deaminase deficiency in skeletal muscle.

Authors:  C Reuschenbach; S Zierz
Journal:  J Pediatr       Date:  1988-04       Impact factor: 4.406

4.  Stain for skeletal muscle adenylate deaminase. An effective tetrazolium stain for frozen biopsy specimens.

Authors:  W N Fishbein; J L Griffin; V W Armbrustmacher
Journal:  Arch Pathol Lab Med       Date:  1980-09       Impact factor: 5.534

5.  Sensitive assay of carnitine palmitoyl transferase activity in tissue homogenates with a modified spectrophotometric method for enzymatic carnitine determination.

Authors:  T Deufel; O H Wieland
Journal:  Clin Chim Acta       Date:  1983-12-15       Impact factor: 3.786

Review 6.  Myoadenylate deaminase deficiency.

Authors:  H H Goebel; A Bardosi
Journal:  Klin Wochenschr       Date:  1987-11-02

7.  Myoadenylate deaminase deficiency: successful symptomatic therapy by high dose oral administration of ribose.

Authors:  N Zöllner; S Reiter; M Gross; D Pongratz; C D Reimers; K Gerbitz; I Paetzke; T Deufel; G Hübner
Journal:  Klin Wochenschr       Date:  1986-12-15

8.  Myoadenylate deaminase deficiency--muscle biopsy and muscle culture in a patient with gout.

Authors:  S DiMauro; A F Miranda; A P Hays; W A Franck; G S Hoffman; R S Schoenfeldt; N Singh
Journal:  J Neurol Sci       Date:  1980-08       Impact factor: 3.181

9.  Myoadenylate deaminase deficiency.

Authors:  J B Shumate; R Katnik; M Ruiz; K Kaiser; C Frieden; M H Brooke; J E Carroll
Journal:  Muscle Nerve       Date:  1979 May-Jun       Impact factor: 3.217

Review 10.  Myoadenylate deaminase deficiency in children.

Authors:  S Ashwal; N Peckham
Journal:  Pediatr Neurol       Date:  1985 May-Jun       Impact factor: 3.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.